James Evans

2.0k total citations
81 papers, 1.5k citations indexed

About

James Evans is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, James Evans has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 18 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in James Evans's work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). James Evans is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). James Evans collaborates with scholars based in United States, United Kingdom and Canada. James Evans's co-authors include Christine Allen, Caitríona M. O’Driscoll, Meenakshi Malhotra, Raphael Darcy, E. Maurice Backett, John F. Cryan, Jianfeng Guo, Pauric Bannigan, J. A. Heady and John Curtis and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Analytical Chemistry.

In The Last Decade

James Evans

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Evans United States 26 467 340 241 189 175 81 1.5k
Abdalla Awidi Jordan 23 742 1.6× 241 0.7× 175 0.7× 239 1.3× 117 0.7× 117 2.0k
Nancy Martin United States 18 393 0.8× 203 0.6× 127 0.5× 215 1.1× 232 1.3× 47 2.4k
Qi Yang China 23 709 1.5× 280 0.8× 168 0.7× 233 1.2× 270 1.5× 70 1.8k
Houyuan Hu China 21 578 1.2× 339 1.0× 459 1.9× 227 1.2× 220 1.3× 44 1.8k
Felicity Y. Han Australia 22 369 0.8× 366 1.1× 299 1.2× 109 0.6× 126 0.7× 71 1.7k
Reza Akhavan‐Sigari Germany 17 475 1.0× 244 0.7× 353 1.5× 185 1.0× 204 1.2× 86 1.6k
Yu Jiang China 21 855 1.8× 436 1.3× 368 1.5× 246 1.3× 224 1.3× 170 2.1k
Qin Chen China 22 726 1.6× 118 0.3× 172 0.7× 124 0.7× 107 0.6× 69 1.8k
Haitao Wu China 22 687 1.5× 289 0.8× 492 2.0× 297 1.6× 292 1.7× 158 2.3k
L.V.K.S. Bhaskar India 20 627 1.3× 179 0.5× 200 0.8× 149 0.8× 149 0.9× 170 2.1k

Countries citing papers authored by James Evans

Since Specialization
Citations

This map shows the geographic impact of James Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Evans more than expected).

Fields of papers citing papers by James Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Evans. The network helps show where James Evans may publish in the future.

Co-authorship network of co-authors of James Evans

This figure shows the co-authorship network connecting the top 25 collaborators of James Evans. A scholar is included among the top collaborators of James Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Evans. James Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Evans, James, et al.. (2025). Creative methods to explore children's experiences of gastrostomy and nasogastric tube feeding during allogeneic bone marrow transplant. European Journal of Oncology Nursing. 76. 102871–102871.
2.
Kim, Theresa W., et al.. (2024). Treating Benzodiazepine Withdrawal in a Bridge Clinic. Journal of Addiction Medicine. 18(6). 649–656. 2 indexed citations
3.
4.
Solomon, Victoria, Mitchell Lee, Zhiheng Cai, et al.. (2023). Associations of ApoE4 status and DHA supplementation on plasma and CSF lipid profiles and entorhinal cortex thickness. Journal of Lipid Research. 64(6). 100354–100354. 8 indexed citations
6.
7.
Bannigan, Pauric, James Evans, & Christine Allen. (2020). Shifting the Paradigm on Cannabis Safety. Cannabis and Cannabinoid Research. 7(1). 3–10. 6 indexed citations
8.
Evans, James, Justin J. Needle, & Shashivadan P. Hirani. (2019). Early outcomes of gastrostomy feeding in paediatric allogenic bone marrow transplantation: A retrospective cohort study. Clinical Nutrition ESPEN. 31. 71–79. 11 indexed citations
9.
Malhotra, Meenakshi, et al.. (2017). Cyclodextrin-siRNA conjugates as versatile gene silencing agents. European Journal of Pharmaceutical Sciences. 114. 30–37. 31 indexed citations
10.
Kshettry, Varun R., et al.. (2017). Utilizing Surgicel for Simple Closure of Postoperative Sellar Defects: The Jefferson Experience. Journal of Neurological Surgery Part B Skull Base. 78(S 01). S1–S156. 1 indexed citations
11.
Evans, James, Meenakshi Malhotra, Jianfeng Guo, et al.. (2016). Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2341–2351. 47 indexed citations
12.
Fitzgerald, Kathleen A., Meenakshi Malhotra, Florence Sallas, et al.. (2015). A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor. International Journal of Pharmaceutics. 499(1-2). 131–145. 68 indexed citations
13.
Evans, James, Joanna McCarthy, Cristina Torres‐Fuentes, et al.. (2015). Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro. Gene Therapy. 22(10). 802–810. 28 indexed citations
14.
O’Mahony, Aoife, Michael F. Cronin, James Evans, et al.. (2014). Biophysical and Structural Characterisation of Nucleic Acid Complexes with Modified Cyclodextrins Using Circular Dichroism. Journal of Pharmaceutical Sciences. 103(5). 1346–1355. 13 indexed citations
15.
Guo, Jianfeng, James Evans, & Caitríona M. O’Driscoll. (2013). Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?. Trends in Molecular Medicine. 19(4). 250–261. 34 indexed citations
16.
Evans, James, et al.. (2008). Brain Abscess and Hereditary Hemorrhagic Telangiectasia. Southern Medical Journal. 101(6). 618–625. 17 indexed citations
17.
Plummer, E. Ruth, Mark R. Middleton, R. Wilson, et al.. (2005). Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide. Clinical Cancer Research. 11. 6 indexed citations
18.
Burke, Wylie, Louise S. Acheson, Kenneth R. Bridges, et al.. (2002). Genetics in Primary Care: A USA Faculty Development Initiative. Public Health Genomics. 5(2). 138–146. 62 indexed citations
19.
Evans, James, et al.. (2000). Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma.. British Journal of Radiology. 73(873). 1018–1020. 13 indexed citations
20.
Evans, James, Stanton Newman, & Sheila Sherlock. (1980). Observations on copper associated protein in childhood liver disease.. Gut. 21(11). 970–976. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026